Effect of H1 and H2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season

Acta Oto-Laryngologica

Volumn 116, Issue 1, 1996, Pages 91-96

  Wang, Deyun ^a   Clement, Peter ^a   Smitz, Johan ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Eosinophil count; H1 and H2 antagonists; Mediators; Nasal allergen challenge; Nasal secretions; Nasal symptoms

Indexed keywords

CETIRIZINE; CIMETIDINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; PLACEBO;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; EOSINOPHILIA; FEMALE; GRASS POLLEN; HAY FEVER; HUMAN; MALE; NOSE AIRWAY RESISTANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RESPIRATORY AIRFLOW; RHINORRHEA; SNEEZING; AIRWAY RESISTANCE; DRUG EFFECT; EOSINOPHIL; MIDDLE AGED; POLLEN; TREATMENT OUTCOME;

ADULT; AIRWAY RESISTANCE; CETIRIZINE; EOSINOPHILS; FEMALE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; POLLEN; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 0029662151     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489609137720     Document Type: Article

References (19)

1. Staub AM, Bovet D. Action de la thymoxéthyldiéthyamine (939F) et des éthers phénoliques sur le choc anaphylactique du cobaye. R Soc Biol 1937; 125: 818-23.
2. 1-receptor antagonist treatment of chronic rhinitis. J Allergy Clin Immunol 1988; 81: 975-80.
3. 1-antagonists. Clin Exp Allergy 1990; 20(Suppl 2): 3-17.
4. 1 antihistamines, terfenadine and astemizole, for hay fever. Thorax 1984; 39: 668-72.
5. Naclerio RM, Togias AG. The nasal allergic reaction: observations on the role of histamine. Clin Exp Allergy 1991; 21(Suppl 2): 13-9.
6. Shelton D, Eiser N. Histamine receptors in the human nose. Clin Otolaryngol 1994; 19: 45-9.
7. Pipkorn U. Allergic rhinitis-Diagnosis and treatment. In: Holgate ST, Church MK, eds. Allergy. London: Gower Medical Publishing, 1993; 18.1-18.10.
8. Wang DY, Clement P, Smitz J, De Waele M, Derde M-P. Correlations between complaints, inflammatory cells and mediators after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Immunol 1995; 106: 278-85.
9. Clement PAR, Van Dishoeck A, Van de Wal J, Stoop P, Hoek T, Van Strick R. Nasal provocation and passive anterior rhinomanometry (PAR). Clin Allergy 1981; 11: 293-301.
10. Biewenga J, Stoop AE, Baker HE, et al. Nasal secretions from patients with polyps and healthy individuals, collected with a new aspiration system: evaluation of total protein and immunoglobulin concentrations. Ann Clin Biochem 1991; 28: 260-6.
11. Wang DY, Clement P, Smitz J, Derde M-P. Concentrations of chemical mediators in nasal secretions of patients with hay fever during natural allergen exposure. Acta Otolarynol (Stockh) 1994; 114: 552-5.
12. Gerth Van Wijk R, Dieges PH. Comparison of nasal responsiveness to histamine, methacholine and phentolamine in allergic rhinitis patients and controls. Clin Allergy 1987; 17: 563-70
13. Connell JT. Quantitative intranasal pollen challenge III. The priming effect in allergic rhinitis. J Allergy 1969; 43: 33-8.
14. Campoli-Richards D, Buckley M, Fitton A. Cetirizine - A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs 1990; 40: 762-81.
15. 2 antagonists in perennial allergic rhinitis. Laryngoscope 1993; 103: 1013-9.
16. 2-receptor blocking agents in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1983; 71:412-7.
17. Dachman WD, Bedarida G, Blaschke TF, Hoffman BB. Allergens, IgE, mediators, inflammatory mechanisms. J Allergy Clin Immunol 1994; 93: 606-14.
18. Settipane G. Chronic rhinitis: an updated clinical review. Am I Rhinol 1991; 5: 199-206.
19. 2 blockade in the challenged allergic nose. J Allergy Clin Immunol: 1982: 70: 373-6.